Mutares Strengthens Chemicals and Materials Portfolio with Planned Synthomer a.s. Acquisition

Mutares Strengthens Chemicals and Materials Portfolio with Planned Synthomer a.s. Acquisition

(IN BRIEF) Mutares SE & Co. KGaA has signed an agreement to acquire Synthomer a.s., a European producer and supplier of acrylic solutions, from Synthomer plc in a carve-out transaction. The deal is expected to close at the end of the third quarter of 2026, subject to customary closing conditions. Synthomer a.s. produces acrylic acids and acrylic esters for a wide range of industrial applications and generated approximately EUR 110 million in carve-out revenues in 2025 with around 300 employees. Mutares said the acquisition represents a new platform investment for its Chemicals & Materials segment and fits its strategy of acquiring businesses with significant operational improvement potential from special situations. The company sees opportunities to strengthen Synthomer’s market position, optimise operations and margins, and build a leading acrylic solutions platform within its chemicals and materials portfolio.

(PRESS RELEASE) MUNICH, 19-Jun-2026 — /EuropaWire/ — Mutares SE & Co. KGaA has signed an agreement to acquire Synthomer a.s. from Synthomer plc, adding a new platform investment to its Chemicals & Materials segment.

The transaction is structured as a carve-out and is expected to close at the end of the third quarter of 2026, subject to customary closing conditions.

Synthomer a.s. is a European producer and supplier of acrylic solutions, with a product portfolio that includes acrylic acids and acrylic esters used across a wide range of industrial applications. The business combines an integrated product offering with a flexible and efficient production setup, allowing it to adjust its product mix and margins according to market needs.

In 2025, Synthomer a.s. generated approximately EUR 110 million in carve-out revenues and employed around 300 people. Mutares said the company provides a strong foundation for further development, supported by operational and commercial improvement potential and a clear path toward profitable growth.

The acquisition strengthens Mutares’ Chemicals & Materials segment and fits the company’s investment strategy of acquiring businesses from special situations where operational improvements can create substantial value.

Johannes Laumann, Chief Investment Officer of Mutares, said Synthomer represents the type of opportunity that matches the firm’s investment model: a high-quality industrial business undergoing transition, with a strong market position and identifiable improvement levers.

Laumann said Mutares looks forward to working with Synthomer’s management team to drive the company’s transformation and build a leading acrylic solutions platform within the Chemicals & Materials segment. He added that the segment is an important growth area for Mutares and a focus for future value creation.

Carve-out revenues refer to the total revenues of the divested business, including intercompany sales, as they would be reported on a standalone basis.

Through the transaction, Mutares is expanding its chemicals and materials portfolio while adding a business with established production capabilities, industrial customer exposure and potential for operational optimisation.

Media Contact:

CROSS ALLIANCE communication GmbH
Susan Hoffmeister
Phone +49 89 125 09 0333
E-Mail: sh@crossalliance.de
www.crossalliance.de

SOURCE: Mutares SE & Co. KGaA